Literature DB >> 11251882

Anti-idiotype antibodies neutralize in vivo the blistering effect of Pemphigus foliaceus IgG.

E Alvarado-Flores1, E Avalos-Díaz, L A Díaz, R Herrera-Esparza.   

Abstract

Idiotypes are molecular clues used to explore the specificity and diversity of immune response. In the present study, anti-idiotype antibodies were used to neutralize the pathogenic effects induced by the injection of pemphigus immunoglobulin(Ig)G into BALB/c mice. To achieve our goal, antidesmoglein 1 IgG was obtained from a patient with pemphigus foliaceus with high titer of antiepithelial antibodies. The IgG was isolated by ion exchange chromatography, then digested by pepsin. F(ab')2 fragments were purified in Sephacryl S-300 and injected in rabbits to produce anti-idiotype antibodies. The rabbit sera reacted with the pemphigus F(ab')2 fragments. Eleven pemphigus foliaceus sera were recognized by the anti-idiotype serum at the light or heavy chains whereas bullous pemphigoid and normal IgG were negative. Neonatal BALB/c mice injected with pemphigus IgG developed intraepidermal blisters, mimicking the clinical and immunopathological features of the pemphigus. In contrast, the animals treated with anti-idiotype antibodies and pemphigus IgG did not develop blisters. Thus, anti-idiotype antibodies neutralize in vivo the pathogenic effects of pemphigus IgG.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251882     DOI: 10.1046/j.1365-3083.2001.00863.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

Review 1.  Autologous therapies in dermatology.

Authors:  Sumir Kumar; Bharat Bhushan Mahajan; Sandeep Kaur; Amarbir Singh
Journal:  J Clin Aesthet Dermatol       Date:  2014-12

Review 2.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

3.  Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display.

Authors:  Aimee S Payne; Ken Ishii; Stephen Kacir; Chenyan Lin; Hong Li; Yasushi Hanakawa; Kazuyuki Tsunoda; Masayuki Amagai; John R Stanley; Don L Siegel
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 4.  Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity.

Authors:  Donna A Culton; Ye Qian; Ning Li; David Rubenstein; Valeria Aoki; Gunter Hans Filhio; Evandro A Rivitti; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-05       Impact factor: 7.094

5.  The caspase pathway as a possible therapeutic target in experimental pemphigus.

Authors:  Deyanira Pacheco-Tovar; Argelia López-Luna; Rafael Herrera-Esparza; Esperanza Avalos-Díaz
Journal:  Autoimmune Dis       Date:  2011-03-02

6.  Autologous serum therapy in chronic urticaria: a promising complement to antihistamines.

Authors:  Panchami Debbarman; Amrita Sil; Piyush Kanti Datta; Debabrata Bandyopadhyay; Nilay Kanti Das
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.